Advertisement
Advertisement
U.S. markets close in 57 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Zentek Ltd. (ZEN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
2.6900-0.1100 (-3.93%)
As of 02:22PM EDT. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.8000
Open2.8200
Bid2.6800 x 0
Ask2.7300 x 0
Day's Range2.6500 - 2.8200
52 Week Range2.1500 - 7.5000
Volume22,215
Avg. Volume46,140
Market Cap267.287M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-0.0870
Earnings DateNov 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ZEN.V

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • ACCESSWIRE

      Zentek Provides Update on Commercial Partnerships

      Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, provides the following updates on its commercial agreements relating to its proprietary ZenGUARD™ antimicrobial coating.

    • ACCESSWIRE

      Zentek Files a Provisional Patent on the use of ZenGUARD(TM) as an Anti-Inflammatory Agent

      Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, has filed a provisional patent on the use of ZenGUARD™ as an anti-inflammatory agent for dermatological conditions. "We continue to work diligently to secure patents for our various intellectual property," said Greg Fenton, CEO for Zentek.

    • ACCESSWIRE

      Zentek Announces Appointment of New Board Director

      GUELPH, ON / ACCESSWIRE / July 5, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Ilse Treurnicht to its Board of Directors.

    Advertisement
    Advertisement